These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 18539368)

  • 1. Functional T-cell responses generated by dendritic cells expressing the early HIV-1 proteins Tat, Rev and Nef.
    Allard SD; Pletinckx K; Breckpot K; Heirman C; Bonehill A; Michiels A; van Baalen CA; Gruters RA; Osterhaus AD; Lacor P; Thielemans K; Aerts JL
    Vaccine; 2008 Jul; 26(29-30):3735-41. PubMed ID: 18539368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients.
    Van Gulck E; Vlieghe E; Vekemans M; Van Tendeloo VF; Van De Velde A; Smits E; Anguille S; Cools N; Goossens H; Mertens L; De Haes W; Wong J; Florence E; Vanham G; Berneman ZN
    AIDS; 2012 Feb; 26(4):F1-12. PubMed ID: 22156965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 evolution in patients undergoing immunotherapy with Tat, Rev, and Nef expressing dendritic cells followed by treatment interruption.
    de Goede AL; van Deutekom HW; Vrancken B; Schutten M; Allard SD; van Baalen CA; Osterhaus AD; Thielemans K; Aerts JL; Keşmir C; Lemey P; Gruters RA
    AIDS; 2013 Nov; 27(17):2679-89. PubMed ID: 24149085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Specific immune responses to human immunodeficiency virus type 1 Gag, Tat, Rev and Nef proteins].
    Zhai S; Kang WZ; Yu X; Wang SY; Walker BD; Altfeld M; Sun YT
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Mar; 21(2):175-9. PubMed ID: 15766402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous activation of viral antigen-specific memory CD4+ and CD8+ T-cells using mRNA-electroporated CD40-activated autologous B-cells.
    Van den Bosch GA; Van Gulck E; Ponsaerts P; Nijs G; Lenjou M; Apers L; Kint I; Heyndrickx L; Vanham G; Van Bockstaele DR; Berneman ZN; Van Tendeloo VF
    J Immunother; 2006; 29(5):512-23. PubMed ID: 16971807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of CEA with both CRT and TAT PTD induces potent anti-tumor immune responses in RNA-pulsed DC vaccination.
    Kim SG; Park MY; Kim CH; Sohn HJ; Kim HS; Park JS; Kim HJ; Oh ST; Kim TG
    Vaccine; 2008 Nov; 26(50):6433-40. PubMed ID: 18812201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lumenal part of the DC-LAMP protein is not required for induction of antigen-specific T cell responses by means of antigen-DC-LAMP messenger RNA-electroporated dendritic cells.
    De Keersmaecker B; Heirman C; Allard S; Bonehill A; Corthals J; Thielemans K; Aerts JL
    Hum Gene Ther; 2010 Apr; 21(4):479-85. PubMed ID: 19903083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Robust CD4+ and CD8+ T cell responses to SIV using mRNA-transfected DC expressing autologous viral Ag.
    Melhem NM; Liu XD; Boczkowski D; Gilboa E; Barratt-Boyes SM
    Eur J Immunol; 2007 Aug; 37(8):2164-73. PubMed ID: 17615585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tat mammaglobin fusion protein transduced dendritic cells stimulate mammaglobin-specific CD4 and CD8 T cells.
    Viehl CT; Tanaka Y; Chen T; Frey DM; Tran A; Fleming TP; Eberlein TJ; Goedegebuure PS
    Breast Cancer Res Treat; 2005 Jun; 91(3):271-8. PubMed ID: 15952060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8(+) T cells.
    López M; Soriano V; Rallón N; Cascajero A; González-Lahoz J; Benito JM
    Eur J Immunol; 2008 Jun; 38(6):1548-58. PubMed ID: 18421792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption.
    Allard SD; De Keersmaecker B; de Goede AL; Verschuren EJ; Koetsveld J; Reedijk ML; Wylock C; De Bel AV; Vandeloo J; Pistoor F; Heirman C; Beyer WE; Eilers PH; Corthals J; Padmos I; Thielemans K; Osterhaus AD; Lacor P; van der Ende ME; Aerts JL; van Baalen CA; Gruters RA
    Clin Immunol; 2012 Mar; 142(3):252-68. PubMed ID: 22177848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV escape from natural killer cytotoxicity: nef inhibits NKp44L expression on CD4+ T cells.
    Fausther-Bovendo H; Sol-Foulon N; Candotti D; Agut H; Schwartz O; Debré P; Vieillard V
    AIDS; 2009 Jun; 23(9):1077-87. PubMed ID: 19424050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 Tat addresses dendritic cells to induce a predominant Th1-type adaptive immune response that appears prevalent in the asymptomatic stage of infection.
    Fanales-Belasio E; Moretti S; Fiorelli V; Tripiciano A; Pavone Cossut MR; Scoglio A; Collacchi B; Nappi F; Macchia I; Bellino S; Francavilla V; Caputo A; Barillari G; Magnani M; Laguardia ME; Cafaro A; Titti F; Monini P; Ensoli F; Ensoli B
    J Immunol; 2009 Mar; 182(5):2888-97. PubMed ID: 19234184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic and functional characteristics of HIV-specific CD8 T cells and gag sequence variability after autologous dendritic cells based therapeutic vaccine.
    López A; van der Lubbe N; Sánchez-Palomino S; Arnedo M; Nomdedeu M; Castro P; Guilà M; Maleno MJ; García F; Gallart T; Gatell JM; Plana M
    Vaccine; 2009 Oct; 27(44):6166-78. PubMed ID: 19712765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poor recognition of HIV-1 Nef protein by CD8 T cells from HIV-1-infected children: impact of age.
    Buseyne F; Scott-Algara D; Corre B; Porrot F; Monchatre E; Bellal N; Burgard M; Rouzioux C; Blanche S; Rivière Y
    Virology; 2006 Oct; 354(2):271-9. PubMed ID: 16904156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro human immunodeficiency virus eradication by autologous CD8(+) T cells expanded with inactivated-virus-pulsed dendritic cells.
    Lu W; Andrieu JM
    J Virol; 2001 Oct; 75(19):8949-56. PubMed ID: 11533158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic activity and safety of autologous HIV RNA-electroporated dendritic cells in HIV-1 infected patients receiving antiretroviral therapy.
    Routy JP; Boulassel MR; Yassine-Diab B; Nicolette C; Healey D; Jain R; Landry C; Yegorov O; Tcherepanova I; Monesmith T; Finke L; Sékaly RP
    Clin Immunol; 2010 Feb; 134(2):140-7. PubMed ID: 19889582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-tumor CD8+ T cell immunity elicited by HIV-1-based virus-like particles incorporating HPV-16 E7 protein.
    Di Bonito P; Grasso F; Mochi S; Petrone L; Fanales-Belasio E; Mei A; Cesolini A; Laconi G; Conrad H; Bernhard H; Dembek CJ; Cosma A; Santini SM; Lapenta C; Donati S; Muratori C; Giorgi C; Federico M
    Virology; 2009 Dec; 395(1):45-55. PubMed ID: 19800648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoregulatory effects of HIV-1 Nef protein.
    Quaranta MG; Mattioli B; Giordani L; Viora M
    Biofactors; 2009; 35(2):169-74. PubMed ID: 19449444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoprevalence of the CD4+ T-cell response to HIV Tat and Vpr proteins is provided by clustered and disperse epitopes, respectively.
    Castelli FA; Houitte D; Munier G; Szely N; Lecoq A; Briand JP; Muller S; Maillere B
    Eur J Immunol; 2008 Oct; 38(10):2821-31. PubMed ID: 18828138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.